Publications
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Anti-NMDAR Antibodies in Demyelinating Diseases2017 | Second Faculty of Medicine, Third Faculty of Medicine
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | Second Faculty of Medicine
- Current options in the treatment of multiple sclerosis2010 | Second Faculty of Medicine
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | Second Faculty of Medicine
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | Second Faculty of Medicine
- Assessment of IgG and IgM antibodies in cerebrospinal fluid cells by the immunocytochemical method2001 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- CSF findings in patients with neuroborreliosis treated by ceftizoxime1997 | Second Faculty of Medicine, Central Library of Charles University
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
Loading network view...